The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

[1]  D. de Zeeuw,et al.  Evaluation of measures of urinary albumin excretion. , 2006, American journal of epidemiology.

[2]  Lawrence A Leiter,et al.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. , 2006, The Canadian journal of cardiology.

[3]  F. McAlister.  The Canadian Hypertension Education Program--a unique Canadian initiative. , 2006, The Canadian journal of cardiology.

[4]  Lawrence Joseph,et al.  The role of global risk assessment in hypertension therapy. , 2006, The Canadian journal of cardiology.

[5]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[6]  S. Oparil,et al.  Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.

[7]  P. Okin,et al.  Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE Study , 2006, Journal of hypertension.

[8]  R. Agarwal,et al.  Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. , 2006, Kidney international.

[9]  E. Schiffrin,et al.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. , 2006, The Canadian journal of cardiology.

[10]  Yutaka Imai,et al.  White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. , 2005, Archives of internal medicine.

[11]  Alexander G Logan,et al.  The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. , 2005, The Canadian journal of cardiology.

[12]  E. Schiffrin,et al.  The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. , 2005, The Canadian journal of cardiology.

[13]  P. Elliott,et al.  Evaluation of measures of urinary albumin excretion in epidemiologic studies. , 2004, American journal of epidemiology.

[14]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[15]  Gilles Chatellier,et al.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. , 2004, JAMA.

[16]  R. Cooper,et al.  Hypertension Treatment and Control in Five European Countries, Canada, and the United States , 2004, Hypertension.

[17]  F. McAlister,et al.  The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. , 2004, The Canadian journal of cardiology.

[18]  E. Schiffrin,et al.  The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. , 2004, The Canadian journal of cardiology.

[19]  E. Topol,et al.  The rudimentary phase of personalised medicine: coronary risk scores , 2003, The Lancet.

[20]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[21]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[22]  Thomas G. Pickering,et al.  What is the white-coat effect and how should it be measured? , 2002, Blood pressure monitoring.

[23]  R. Stevens,et al.  UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine , 2002, Stroke.

[24]  E. Schiffrin,et al.  The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. , 2002, The Canadian journal of cardiology.

[25]  E. Schiffrin,et al.  The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. , 2002, The Canadian journal of cardiology.

[26]  Reversed white-coat hypertension: definition, mechanisms and prognostic implications. , 2002, Journal of hypertension.

[27]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .

[28]  D. Levy,et al.  Impact of high-normal blood pressure on the risk of cardiovascular disease. , 2002, The New England journal of medicine.

[29]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[30]  Daniel Levy,et al.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study , 2001, The Lancet.

[31]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[32]  F. McAlister,et al.  The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. , 2001, The Canadian journal of cardiology.

[33]  F. McAlister,et al.  A novel process for updating recommendations for managing hypertension: rationale and methods. , 2000, The Canadian journal of cardiology.

[34]  J. Bakker,et al.  Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. , 2000, Clinical radiology.

[35]  G. Bakris,et al.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.

[36]  R B D'Agostino,et al.  Primary and subsequent coronary risk appraisal: new results from the Framingham study. , 2000, American heart journal.

[37]  L. Coupal,et al.  Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. , 1998, Archives of internal medicine.

[38]  R. Deber,et al.  What role do patients wish to play in treatment decision making? , 1996, Archives of internal medicine.

[39]  W. Kannel.  Blood pressure as a cardiovascular risk factor: prevention and treatment. , 1996, JAMA.

[40]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.